The British Neuroscience Association (BNA) is a key player in the neuroscience sector, supporting professionals and promoting interdisciplinary collaboration. Chief Executive Dr Laura Ajram highlights the importance of bridging advanced neurological research with public understanding and the latest developments in the field.
Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD)...
Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease
From the...
Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to...
Mental Health Europe and the University of Kent-Tizard Centre have launched a new report which has revealed the flaws and human rights challenges in...
Cecilia Van Cauwenberghe from Frost & Sullivan explores advancing opportunities for personalised treatment of chronic kidney disease (CKD) and research into membranous nephropathy (MN)
According...
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are...
EUPHA Executive Director, Dineke Zeegers Paget explores the importance of improving public health in Europe
The European Public Health Association – EUPHA – is an...
Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve
Every...
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s
My PD Journey is a multi-stakeholder...
Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.
